Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)
China flag China · Delayed Price · Currency is CNY
116.81
+9.95 (9.31%)
Apr 29, 2026, 3:07 PM CST

SHE:300436 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22 2021 - 2017
Market Capitalization
18,60414,1995,2034,0826,2377,626
Upgrade
Market Cap Growth
239.17%172.88%27.47%-34.55%-18.22%40.97%
Upgrade
Enterprise Value
18,91514,4745,5704,3946,2567,352
Upgrade
Last Close Price
116.8189.1532.6725.6339.1648.03
Upgrade
Forward PE
-46.4346.4346.4346.4346.43
Upgrade
PS Ratio
44.6834.1011.799.6616.1720.59
Upgrade
PB Ratio
53.7241.0013.117.176.537.26
Upgrade
P/TBV Ratio
333.45254.49105.0024.678.118.81
Upgrade
P/OCF Ratio
--251.27---
Upgrade
EV/Sales Ratio
45.4334.7612.6210.3916.2219.85
Upgrade
EV/EBITDA Ratio
-2216.31----
Upgrade
Debt / Equity Ratio
1.541.321.120.810.330.18
Upgrade
Debt / EBITDA Ratio
70.9856.54----
Upgrade
Net Debt / Equity Ratio
0.880.700.750.450.08-0.20
Upgrade
Net Debt / EBITDA Ratio
52.2637.06-9.89-1.83-0.437.04
Upgrade
Net Debt / FCF Ratio
-2.70-2.56-6.45-0.68-0.231.07
Upgrade
Asset Turnover
0.300.290.290.270.260.30
Upgrade
Inventory Turnover
1.241.311.792.072.162.09
Upgrade
Quick Ratio
0.610.650.420.500.721.50
Upgrade
Current Ratio
1.021.080.710.750.971.82
Upgrade
Return on Equity (ROE)
-70.95%-65.09%-35.71%-49.17%-14.02%-4.19%
Upgrade
Return on Assets (ROA)
-3.87%-3.78%-5.11%-8.53%-9.56%-4.13%
Upgrade
Return on Invested Capital (ROIC)
-14.65%-13.39%-16.40%-22.88%-24.04%-10.80%
Upgrade
Return on Capital Employed (ROCE)
-9.70%-9.30%-14.40%-20.90%-20.70%-7.10%
Upgrade
Earnings Yield
-1.17%-1.53%-3.00%-8.54%-2.04%-0.46%
Upgrade
FCF Yield
-0.51%-0.67%-0.89%-9.21%-5.06%-2.52%
Upgrade
Buyback Yield / Dilution
-0.00%-0.00%0.00%-0.06%-6.54%-6.43%
Upgrade
Total Shareholder Return
-0.00%-0.00%0.00%-0.06%-6.54%-6.43%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.